术前增强CT联合临床数据预测混合型肝细胞-胆管癌微血管侵犯
回顾性纳入60例混合型肝细胞-胆管癌患者,分析术前增强CT特征与临床数据预测微血管侵犯。多因素分析显示动脉期瘤周强化(OR 6.514)和高血清PIVKA-II水平(OR 6.810)为独立预测因子,两者联合预测敏感度93.9%,AUC 0.763。
要点
- 动脉期瘤周强化是MVI的独立影像预测因子(OR 6.514,P=0.012)。
- 高血清PIVKA-II水平是MVI的独立临床预测因子(OR 6.810,P=0.005)。
- 两者联合预测MVI敏感度达93.9%,AUC 0.763。
局限性
- 样本量较小(共60例)。
- 回顾性单中心研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Microvascular invasion (MVI) is significantly associated with prognosis in combined hepatocellular-cholangiocarcinoma (cHCC-CCA) patients. The study aimed to explore the value of preoperative contrast-enhanced CT (CECT) features and clinical data in predicting MVI of cHCC-CCA.
METHODS: A total of 33 patients with MVI-positive and 27 with MVI-negative were enrolled, and underwent preoperative CECT imaging from January 2016 to December 2021. Preoperative clinical data and CECT imaging features were retrospectively analyzed. Univariable and multivariable logistic regression analysis were performed to identify potential predictors of MVI in cHCC-CCA. The diagnostic performance was evaluated by the receiver operating characteristic (ROC) curve and its area under the curve (AUC) value.
RESULTS: The mean age of the patients was 54.0 ± 10.3 years, and 53 of the 60 patients (88.3%) were male. Preoperative imaging features on CECT (non-smooth contour and arterial phase peritumoral enhancement) and clinical data (hepatitis B virus (HBV) infection and protein induced by vitamin K absence or antagonist-II (PIVKA-II)) were highly distinct between those in MVI-positive group and MVI-negative group. On multivariable logistic analysis, arterial phase peritumoral enhancement (odds ratio (OR), 6.514; 95% confidence interval (CI), 1.588-26.728, p = 0.012) and high serum PIVKA-II level (OR, 6.810; 95% CI, 1.796-25.820, p = 0.005) were independent predictors associated with MVI of cHCC-CCA. The combination of these two predictors had high sensitivity (31/33, 93.9%; 95% CI, 80.4% - 98.3%) in the prediction of MVI with an area under the receiver operating characteristic (ROC) curve of 0.763 (95% CI, 0.635-0.863).
CONCLUSIONS: The findings indicated that arterial phase peritumoral enhancement on preoperative CECT and high serum PIVKA-II level were identified as potential predictors for MVI in cHCC-CCA patients.
引用
- Zhang, Dong, Li, et al. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data. Eur J Radiol. 2023. PMID: 37121101. doi:10.1016/j.ejrad.2023.110839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。